Autorisation d’accès précoce refusée à la spécialité EMCITATE (tiratricol) dans l'indication « traitement de la thyrotoxicose périphérique chez les patients atteints d’un déficit en transporteur 8 de monocarboxylate (MCT8) (syndrome d’Allan-Herndon-Dudley), dès la naissance. »
See also
HAS opinions and decisions
07/08/2025
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
mTzqY4hU18yMHwmj